Literature DB >> 24198482

Biosensors: the new wave in cancer diagnosis.

Brian Bohunicky1, Shaker A Mousa.   

Abstract

The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.

Entities:  

Keywords:  biosensor; biotechnology; cancer detection; diagnosis; nanotechnology; oncogene; point-of-care

Year:  2010        PMID: 24198482      PMCID: PMC3781701          DOI: 10.2147/NSA.S13465

Source DB:  PubMed          Journal:  Nanotechnol Sci Appl        ISSN: 1177-8903


  54 in total

Review 1.  Applications of nanobiotechnology in clinical diagnostics.

Authors:  Kewal K Jain
Journal:  Clin Chem       Date:  2007-09-21       Impact factor: 8.327

Review 2.  Biosensors for cancer markers diagnosis.

Authors:  Ibtisam E Tothill
Journal:  Semin Cell Dev Biol       Date:  2009-02-04       Impact factor: 7.727

3.  Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.

Authors:  C Stirzaker; D S Millar; C L Paul; P M Warnecke; J Harrison; P C Vincent; M Frommer; S J Clark
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

4.  Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.

Authors:  E Jäger; E Stockert; Z Zidianakis; Y T Chen; J Karbach; D Jäger; M Arand; G Ritter; L J Old; A Knuth
Journal:  Int J Cancer       Date:  1999-10-22       Impact factor: 7.396

5.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 6.  Development of biosensors for cancer clinical testing.

Authors:  Avraham Rasooly; James Jacobson
Journal:  Biosens Bioelectron       Date:  2006-02-02       Impact factor: 10.618

7.  The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience.

Authors:  D S Smith; P A Humphrey; W J Catalona
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

Review 8.  Current issues in ER and HER2 testing by IHC in breast cancer.

Authors:  Allen M Gown
Journal:  Mod Pathol       Date:  2008-05       Impact factor: 7.842

9.  Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma.

Authors:  V Greger; N Debus; D Lohmann; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

Review 10.  Epigenetic change in pituitary tumorigenesis.

Authors:  W E Farrell; R N Clayton
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

View more
  36 in total

1.  Microfabricated Systems and Assays for Studying the Cytoskeletal Organization, Micromechanics, and Motility Patterns of Cancerous Cells.

Authors:  Sabil Huda; Didzis Pilans; Monika Makurath; Thomas Hermans; Kristiana Kandere-Grzybowska; Bartosz A Grzybowski
Journal:  Adv Mater Interfaces       Date:  2014-08-28       Impact factor: 6.147

Review 2.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors.

Authors:  Rasheena Edmondson; Jessica Jenkins Broglie; Audrey F Adcock; Liju Yang
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

3.  Amperometric immunoassay for the carcinoembryonic antigen by using a peroxidase mimic consisting of palladium nanospheres functionalized with glutathione-capped gold nanoparticles on graphene oxide.

Authors:  Zhaoling Tan; Linlin Cao; Yuying Yang; Qin Yan; Qing Liu; Wen Zhang; Pingping Zhao; Yueyun Li; Daopeng Zhang
Journal:  Mikrochim Acta       Date:  2019-10-12       Impact factor: 5.833

Review 4.  Multi-Dimensional Nanostructures for Microfluidic Screening of Biomarkers: From Molecular Separation to Cancer Cell Detection.

Authors:  Elaine Ng; Kaina Chen; Annie Hang; Abeer Syed; John X J Zhang
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 3.934

5.  Encapsulation of sodium radio-iodide in fullerene C₆₀.

Authors:  Alejandro Valderrama; José Guzman
Journal:  J Mol Model       Date:  2014-03-01       Impact factor: 1.810

6.  Self-stability of C60 nanocapsules with radio-iodide content and its interaction with calcium atoms.

Authors:  Alejandro Valderrama; Radamés Reynoso; Raúl W Gómez; Vivianne Marquina
Journal:  J Mol Model       Date:  2016-01-09       Impact factor: 1.810

Review 7.  Electrospun Nanofibers for Cancer Therapy.

Authors:  Huanhuan Luo; Tianyang Jie; Li Zheng; Chenglong Huang; Gang Chen; Wenguo Cui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Characteristics of P-Type and N-Type Photoelectrochemical Biosensors: A Case Study for Esophageal Cancer Detection.

Authors:  Joseph-Hang Leung; Hong-Thai Nguyen; Shih-Wei Feng; Sofya B Artemkina; Vladimir E Fedorov; Shang-Chin Hsieh; Hsiang-Chen Wang
Journal:  Nanomaterials (Basel)       Date:  2021-04-21       Impact factor: 5.076

9.  Novel and simple electrochemical biosensor monitoring attomolar levels of miRNA-155 in breast cancer.

Authors:  Ana R Cardoso; Felismina T C Moreira; Rúben Fernandes; M Goreti F Sales
Journal:  Biosens Bioelectron       Date:  2016-02-14       Impact factor: 10.618

Review 10.  Sensitivity-Enhancing Strategies in Optical Biosensing.

Authors:  Youngsun Kim; John Gonzales; Yuebing Zheng
Journal:  Small       Date:  2020-12-28       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.